Clinical Trial Update: Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study) [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the immunogenicity of Haemophilus influenzae type B PRP-OMP vaccines in American Indian and Alaska Native children; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Hib PRP-OMP vaccine (Haemophilus influenzae type b conjugate vaccine PRP-OMP)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Haemophilus Influenzae Type B Infection | Phase 4 | Status: COMPLETED | Results posted: 2024-06-24